AFT Forsyth & Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AFT Forsyth & Company's BMY Position: Q3 2023 in Review
AFT Forsyth & Company sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,518 shares — an estimated $225K sold.
AFT Forsyth & Company first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $717K in Q3 2013. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- AFT Forsyth & Company reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
- AFT Forsyth & Company sold 3,518 Bristol-Myers Squibb shares in Q3 2023, an estimated $225K.
- AFT Forsyth & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
- AFT Forsyth & Company's Bristol-Myers Squibb position peaked at $717K in Q3 2013.
- 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on AFT Forsyth & Company's 13F filing for Q3 2023, filed 7 Nov 2023.